Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review of SHP2 and its role in cancer
Moges Dessale Asmamaw, Xiaojing Shi, Lirong Zhang, et al.
Cellular Oncology (2022) Vol. 45, Iss. 5, pp. 729-753
Closed Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 166
Targeting the undruggables—the power of protein degraders
Chao Zhang, Yongbo Liu, Guangchen Li, et al.
Science Bulletin (2024) Vol. 69, Iss. 11, pp. 1776-1797
Open Access | Times Cited: 20
Optogenetics with Atomic Precision─A Comprehensive Review of Optical Control of Protein Function through Genetic Code Expansion
Maura E. Charette, Carolyn Rosenblum, Olivia Shade, et al.
Chemical Reviews (2025)
Open Access | Times Cited: 2
Identification of GDC-1971 (RLY-1971), a SHP2 Inhibitor Designed for the Treatment of Solid Tumors
Alexander M. Taylor, Bret R. Williams, Fabrizio Giordanetto, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 19, pp. 13384-13399
Closed Access | Times Cited: 27
Macrophage SHP2 Deficiency Alleviates Diabetic Nephropathy via Suppression of MAPK/NF-κB– Dependent Inflammation
Xue Han, Jiajia Wei, Ruyi Zheng, et al.
Diabetes (2024) Vol. 73, Iss. 5, pp. 780-796
Open Access | Times Cited: 10
SH2 Domains: Folding, Binding and Therapeutical Approaches
Awa Diop, Daniele Santorelli, Francesca Malagrinò, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15944-15944
Open Access | Times Cited: 36
Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
Victor Hugo Fonseca de Jesus, Maria Cecília Mathias-Machado, João Paulo Fogacci de Farias, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5015-5015
Open Access | Times Cited: 17
Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes
Jonathan D. Taylor, Nathalie Barrett, Sergio Martínez Cuesta, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 8
Traditional Chinese medicine inhibits PD-1/PD-L1 axis to sensitize cancer immunotherapy: a literature review
Huilan Zheng, Gang Wang, Ming Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 14
Combined Inhibition of PI3K and STAT3 signaling effectively inhibits bladder cancer growth
Weidong Peng, Haojie Zhang, Mingwei Yin, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Design, Synthesis and Antitumor Activity of a Novel Class of SHP2 Allosteric Inhibitors with a Furanyl Amide-Based Scaffold
Chengchun Zhu, Haiyang Zhao, Wenting Yang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 13305-13323
Closed Access | Times Cited: 5
MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer
Yoshihiro Morimoto, Nami Yamashita, Haruka Hirose, et al.
Cancer Letters (2023) Vol. 559, pp. 216116-216116
Open Access | Times Cited: 13
Cancer‐derived non‐coding RNAs endow tumor microenvironment with immunosuppressive properties
Tong Hu, Run Shi, Yunru Gu, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11
A Novel Gain-of-Signal Assay to Detect Targeted Protein Degradation
Megan T. Hoffman, Keith M. Cheah, K. Dane Wittrup
ACS Synthetic Biology (2024) Vol. 13, Iss. 1, pp. 220-229
Closed Access | Times Cited: 4
TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway
Fen Xue, Lifen Liu, Xueqiang Tao, et al.
Journal of Gynecologic Oncology (2024) Vol. 35, Iss. 5
Open Access | Times Cited: 4
Allostery Frustrates the Experimentalist
Stefano Gianni, Per Jemth
Journal of Molecular Biology (2022) Vol. 435, Iss. 4, pp. 167934-167934
Open Access | Times Cited: 17
Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases
Jiao Pang, Chang-Qian Cen, Tian Yuan, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Protein kinase A suppresses anti-proliferative effect of interferon-α in hepatocellular carcinoma by activation of protein tyrosine phosphatase SHP2
Yuwen Sheng, Yuan Lin, Zhe Qiang, et al.
Journal of Biological Chemistry (2025), pp. 108195-108195
Open Access
SHP2 promotes the epithelial-mesenchymal transition in triple negative breast cancer cells by regulating β-catenin
Shihan Qian, Jingjing Zhu, Qing Han, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access
Computational Elucidation of a Monobody Targeting the Phosphatase Domain of SHP2
Yang Wang, Xin Qiao, Ruidi Zhu, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 217-217
Open Access
Covalent-Allosteric Inhibitors: Do We Get the Best of Both Worlds?
Hui Tao, Bo Yang, Atena Farhangian, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Synthetic Lethality of SHP2 and XIAP Suppresses Proliferation and Metastasis in KRAS‐mutant Nonsmall Cell Lung Cancer
Naijie Fu, Yuwen Sheng, Zhe Fan, et al.
Advanced Science (2025)
Open Access
Pioneer in Molecular Biology: Conformational Ensembles in Molecular Recognition, Allostery, and Cell Function
Ruth Nussinov
Journal of Molecular Biology (2025), pp. 169044-169044
Open Access
Combination therapy and dual-target inhibitors based on cyclin-dependent kinases (CDKs): Emerging strategies for cancer therapy
Qi Hao, Wenzhe Zhao, Zhijia Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117465-117465
Closed Access
DeepPath: Overcoming data scarcity for protein transition pathway prediction using physics-based deep learning
Yui Tik Pang, Katie M. Kuo, Lixinhao Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Page 1 - Next Page

Scroll to top